ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05340	Primary immunodeficiency	13/132	30/7206	1.32120830941e-15
ko04060	Cytokine-cytokine receptor interaction	23/132	191/7206	3.55499916814e-13
ko04650	Natural killer cell mediated cytotoxicity	16/132	97/7206	1.45041579505e-11
ko05330	Allograft rejection	9/132	24/7206	1.8302224262e-10
ko04612	Antigen processing and presentation	13/132	77/7206	9.778966469e-10
ko05152	Tuberculosis	18/132	187/7206	6.52274185383e-09
ko05140	Leishmaniasis	12/132	75/7206	8.44999108366e-09
ko05332	Graft-versus-host disease	7/132	18/7206	1.58792944381e-08
ko04380	Osteoclast differentiation	15/132	134/7206	1.69817225049e-08
ko04660	T cell receptor signaling pathway	14/132	124/7206	4.70676383353e-08
ko05145	Toxoplasmosis	14/132	126/7206	5.78069227109e-08
ko05144	Malaria	9/132	45/7206	8.96059258573e-08
ko04145	Phagosome	15/132	162/7206	2.19123040952e-07
ko05321	Inflammatory bowel disease (IBD)	9/132	56/7206	6.46152511931e-07
ko05320	Autoimmune thyroid disease	7/132	29/7206	6.58310674991e-07
ko04940	Type I diabetes mellitus	7/132	32/7206	1.3561206265e-06
ko04659	Th17 cell differentiation	11/132	106/7206	3.24940426618e-06
ko04064	NF-kappa B signaling pathway	10/132	96/7206	8.9594295468e-06
ko05310	Asthma	5/132	17/7206	9.91382384792e-06
ko05168	Herpes simplex infection	13/132	182/7206	2.58890520178e-05
ko05150	Staphylococcus aureus infection	6/132	36/7206	4.1817058224e-05
ko04672	Intestinal immune network for IgA production	6/132	37/7206	4.91667840931e-05
ko05162	Measles	10/132	120/7206	6.3553106183e-05
ko04062	Chemokine signaling pathway	13/132	201/7206	7.30592768432e-05
ko04666	Fc gamma R-mediated phagocytosis	10/132	122/7206	7.31621301611e-05
ko04620	Toll-like receptor signaling pathway	9/132	100/7206	8.22138681892e-05
ko04640	Hematopoietic cell lineage	7/132	64/7206	0.000153774656183
ko05323	Rheumatoid arthritis	8/132	89/7206	0.000208356175578
ko05164	Influenza A	11/132	167/7206	0.00022847797313
ko04658	Th1 and Th2 cell differentiation	8/132	96/7206	0.000351449436779
ko03050	Proteasome	6/132	54/7206	0.000423385308898
ko04670	Leukocyte transendothelial migration	10/132	151/7206	0.00042444288267
ko05416	Viral myocarditis	6/132	55/7206	0.000468176103615
ko04664	Fc epsilon RI signaling pathway	7/132	77/7206	0.000488761592334
ko04514	Cell adhesion molecules (CAMs)	9/132	130/7206	0.000599403267734
ko04630	Jak-STAT signaling pathway	9/132	132/7206	0.000669789381172
ko05133	Pertussis	7/132	87/7206	0.0010208285975
ko04662	B cell receptor signaling pathway	7/132	88/7206	0.0010924079066
ko05161	Hepatitis B	10/132	173/7206	0.00122464484519
ko05146	Amoebiasis	7/132	99/7206	0.00216969006581
ko05142	Chagas disease (American trypanosomiasis)	8/132	130/7206	0.00256202282887
ko04622	RIG-I-like receptor signaling pathway	5/132	62/7206	0.00536593718059
ko04621	NOD-like receptor signaling pathway	8/132	157/7206	0.00799466156546
ko05167	Kaposi's sarcoma-associated herpesvirus infection	9/132	191/7206	0.00822724469364
ko05166	HTLV-I infection	12/132	292/7206	0.0111157462242
ko04610	Complement and coagulation cascades	5/132	79/7206	0.0146162830719
ko04210	Apoptosis	8/132	180/7206	0.0172567777305
ko05143	African trypanosomiasis	3/132	32/7206	0.0202318765274
ko05322	Systemic lupus erythematosus	7/132	151/7206	0.0206118370539
ko04080	Neuroactive ligand-receptor interaction	2/132	423/7206	0.0241878530375
ko04611	Platelet activation	7/132	163/7206	0.0297621135142
ko05132	Salmonella infection	5/132	98/7206	0.0335369318182
ko04144	Endocytosis	12/132	342/7206	0.03433946757
ko05020	Prion diseases	3/132	40/7206	0.0362770321799
ko04217	Necroptosis	7/132	178/7206	0.0446305137743
ko05134	Legionellosis	4/132	74/7206	0.0463098156733